The DEA may be close to reaching a decision on rescheduling marijuana to recognize the medical benefits. The DEA spokesman Russ Baer said no determination has been made yet on rescheduling pot, but ...

The ordeal began in 2018 when MMJ Biopharma Cultivation submitted its application for a DEA bulk manufacturing registration (grow pharmaceutical marijuana). The company's objective was clear and ...

Duane Boise CEO of MMJ International Holdings stated, “When private citizens or companies fall short of compliance, the DEA acts swiftly ... stalled vital medical marijuana research, it's ...

Some 36 states now permit marijuana to be used medically, and 17 allow recreational use. Yet researchers who wish to study the drug’s health effects have been limited since 1968 to a single legal ...

The agency's sluggish processing of cultivation applications (mandated by the Medical Marijuana and Cannabidiol Research Expansion Act directly hinders MMJ's ability to proceed. Catch-22: The DEA ...

A t a congressional hearing on Tuesday, the head of the U.S. Drug Enforcement Administration (DEA), Anne Milgram, declined to comment on her agency’s recent marijuana rescheduling determination ...